Owner University of Maryland, Baltimore

Inventors Carrier, France; Weber, David J; Markowitz, Joseph; MackerelL, Alexander D

Agent Davies Collison Cave

Pub. Number AU-B-2003230705

PCT Number PCT/US03/08678

PCT Pub. Number WO2003/084475

Priority 60/368,835 29.03.02 US

Filing date 28 March 2003

Wipo publication date 20 October 2003

Acceptance publication date 29 May 2008

A61K 31/12 (2006.01) - Ketones

A61K 31/00 (2006.01)

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/185 (2006.01) - Acids

A61K 31/27 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/4035 (2006.01)

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4425 (2006.01) - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 31/47 (2006.01) - Quinolines

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/635 (2006.01)

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine